×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Company: AD BBB Modulation and Transport Technologies
company
1,367 words
KG: Ad
2026-03-28
kind:company
section:companies
topic:bbb-modulation
topic:transport-technology
topic:brain-delivery
topic:receptor-mediated-transcytosis
topic:adsorptive-transcytosis
topic:efflux-pump-inhibition
topic:bbb-normalization
topic:nanocarrier
topic:trojan-horse
topic:alzheimer-disease
Contents
AD BBB Modulation and Transport Technologies
Knowledge Graph
Related Hypotheses (30)
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Purinergic Signaling Polarization Control
Score: 0.55
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Aquaporin-4 Polarization Rescue
Score: 0.51
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
RNA Granule Nucleation Site Modulation
Score: 0.48
APOE-TREM2 Interaction Modulation
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48
Show 25 more
Related Analyses (21)
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed
What delivery mechanisms can achieve therapeutically relevan
drug delivery · failed
What is the optimal BBB opening duration and spatial precisi
neuropharmacology · failed
What is the actual quantitative contribution of FcRn-mediate
neuropharmacology · completed
What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Show 16 more
See Also (15)
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 7 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 7 hypotheses
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 7 hypotheses
Endosomal Sorting Defects in Neurodegeneration
mechanism · Pages share 7 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Cerebral Amyloid Angiopathy Pathway in Neurodegeneratio
mechanism · Pages share 7 hypotheses
Cerebral Amyloid Angiopathy in Neurodegeneration
mechanism · Pages share 7 hypotheses
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 7 hypotheses
Rotigotine and Rivastigmine Combination Therapy for Alz
clinical · Pages share 7 hypotheses
A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 7 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
WNK1 Kinase in Neurodegeneration
mechanism · Pages share 6 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 6 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 6 hypotheses
Show 10 more
Knowledge Graph (1 edges)
TDP-43
associated_with
Ad